Sunshine Biopharma Inc. (SBFMW) stock
SBFMWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SBFM
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 10/30
$0.03+0.00 (+2.00%)
Close on Oct 30, 2026Market cap $11.36MP/E –Yield –
Sunshine Biopharma free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Sunshine Biopharma's free cash flow for the twelve months ending Jun 30, 2026 was -$5.37M. For fiscal 2025 it was -$5.51M. The highest annual figure on record is -$317.62K in fiscal 2016.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$5.51M | – |
| FY2024 | Dec 31, 2024 | -$14.18M | – |
| FY2023 | Dec 31, 2023 | -$8.86M | – |
| FY2022 | Dec 31, 2022 | -$5.44M | – |
| FY2021 | Dec 31, 2021 | -$1.83M | – |
| FY2020 | Dec 31, 2020 | -$658.49K | – |
| FY2019 | Dec 31, 2019 | -$496.66K | – |
| FY2018 | Dec 31, 2018 | -$531.66K | – |
| FY2017 | Dec 31, 2017 | -$547.24K | – |
| FY2016 | Dec 31, 2016 | -$317.62K | – |
| FY2015 | Dec 31, 2015 | -$872.44K | – |
| FY2014 | Dec 31, 2014 | -$538.60K | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$924.99K | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.08M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.61M | – |
| Q3 FY2025 | Sep 30, 2025 | -$754.71K | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.43M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.70M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.51M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.87M | – |
| Q2 FY2024 | Jun 30, 2024 | -$5.55M | – |
| Q1 FY2024 | Mar 31, 2024 | -$3.25M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.31M | – |
| Q3 FY2023 | Sep 30, 2023 | -$466.92K | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.44M | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.12M | – |
| Q4 FY2021 | Dec 31, 2021 | -$312.11K | – |
| Q4 FY2020 | Dec 31, 2020 | -$424.06K | – |
| Q3 FY2020 | Sep 30, 2020 | -$121.38K | – |
| Q4 FY2019 | Dec 31, 2019 | -$128.70K | – |
| Q3 FY2019 | Sep 30, 2019 | -$86.05K | – |
| Q2 FY2019 | Jun 30, 2019 | -$47.95K | – |
| Q1 FY2019 | Mar 31, 2019 | -$233.96K | – |
| Q4 FY2018 | Dec 31, 2018 | -$107.53K | – |
| Q3 FY2018 | Sep 30, 2018 | -$175.88K | – |
| Q2 FY2018 | Jun 30, 2018 | -$75.02K | – |
| Q1 FY2018 | Mar 31, 2018 | -$173.24K | – |
| Q4 FY2017 | Dec 31, 2017 | -$213.20K | – |
| Q3 FY2017 | Sep 30, 2017 | -$125.89K | – |
| Q2 FY2017 | Jun 30, 2017 | -$100.11K | – |
| Q1 FY2017 | Mar 31, 2017 | -$108.04K | – |
| Q4 FY2016 | Dec 31, 2016 | -$32.29K | – |
| Q3 FY2016 | Sep 30, 2016 | -$62.99K | – |